Two Weeks for Early Registration Discounts!
The second annual European Post-Approval Summit will be held 21-22 September 2011 at the Kongresshaus Zürich in Zürich, Switzerland. This provocative case-based program is focused on designing and operating high quality patient registries and post-approval studies in Europe and how they will be evaluated by other stakeholders.
The agenda will cover the evolving role of patient registries and post-approval research, guidelines and considerations for risk management and pharmacoepidemiology studies, effectiveness research and market access, and practical considerations.
Speakers will represent government, industry, and academia, including:
- European Commission
- European Medicines Agency
- Boehringer Ingelheim GmbH
- Genzyme
- Novo Nordisk A/S
- UCB Pharma
- Outcome
- Erasmus University
- Harvard Medical School
- University of Helsinki
View the full agenda at www.europe.postapproval.org.
Register online at www.europe.postapproval.org.
Register by 22 July and save €150. Your registration includes all conference materials, breakfast, lunch, and admittance to the evening networking reception.
We look forward to seeing you in September!
Best Regards,
The Committee for the Post-Approval Summit
(617)621-6426
postapproval@postapproval.org
201 Broadway, Box 12, Cambridge, MA 02139
|
